Background: The frequency of pregnancies during dialysis is increasing. This condition requires changes in the dialysis schedule and nutritional approach.
Aim: To report the experience in six patients with terminal kidney disease who became pregnant.
Objective: To compare changes in mammographic density and the expression of markers of proliferation (Ki67) and apoptosis (Bcl-2) after 1 year of treatment with tibolone and continuous conjugated equine estrogens combined with medroxyprogesterone acetate (CEE-MPA).
Design: Comparative, randomized, evaluator-blinded study.
Setting: City research hospital.